New tests for the diagnosis of inherited neuromuscular diseases
Project is being carried out within the ERDF 18.104.22.168. activity „Support for Science and Research”
Project agreement Nr. 2010/0223/2DP/22.214.171.124.0/10/APIA/VIAA/025
Project duration: 36 months (01.01.2011.-31.12.2013.)
Project funding: 271 175,00 LVL
Project leader: Dr. med. Baiba Lāce
General aim of the project: Improvement of general health of society, through improvement diagnostics of neuromuscular diseases.
Specific aim of the project: Creating new diagnostic approach for the inherited muscle dystrophies in the medical science.
1) New diagnostic test will be developed with selected mutation panel, verification and prototype modeling and production. In the production of prototype will be joined advances and technolgies from the several scientific fields: medicine, biomedicine, biotechnology and bioinformatics. New product agrees with the definition of introduction of the new inovative product.
2) Nucleotide expansion and reduction diagnostic test introduction and validation.
3) Neuromuscular disease patient national registry introduction.
It is planned to develop new tests for genetic diagnostics and establish national registry of neuromuscular disease patients.